Shop ACC / AHA / HRS Management of Patients ... Sudden Cardiac Death

Management of Patients With Ventricular Arrythmias and the Prevention of Sudden Cardiac Death

Published: August 2018
$17.95
Print Copy Information:
  • 29 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Graded recommendations for:
    • Syncope
    • 12-lead ECG and Exercise Testing
    • Ambulatory Electrocardiography
    • Implanted Cardiac Monitors
    • Noninvasive Cardiac Imaging
    • Assessment
    • Genetic Counselling
    • Invasive Imaging: Cardiac Catheterization
    • Electrophysiological Study
    • Pharmacological Prevention of SCD
    • Surgery and Revascularization Procedures in Patients With Ischemic Heart Disease
    • Surgery for Arrhythmia Management
    • Autonomic Modulation
    • Management of Cardiac Arrest
    • Secondary Prevention of SCD in Patients with Ischemic Heart Disease
    • Coronary Artery Spasm
    • Primary Prevention of SCD in Patients with Ischemic Heart Disease
    • Recurrent VA in Patients With Ischemic Heart Disease
    • Nonischemic Cardiomyopathy (NICM)
    • Secondary Prevention of SCD in Patients With NICM
    • Primary Prevention of SCD in Patients With NICM
    • Treatment of Recurrent VA in Patients With NICM
    • Arrhythmogenic Right Ventricular Cardiomyopathy
    • Hypertrophic Cardiomyopathy (HCM)
    • Myocarditis
    • Cardiac Sarcoidosis
    • HFr EF
    • LVAD
    • ICD Use After Heart Transplantation
    • Neuromuscular Disorders
    • Cardiac Channelopathies
    • Congenital Long QT Syndrome
    • Catecholaminergic Polymorphic Ventricular Tachycardia
    • Brugada Syndrome
    • Early Repolarization “J-wave” Syndrome
    • Short QT Syndrome
    • VA in the Structurally Normal Heart
    • Outflow Tract VA
    • Papillary Muscle VA (PVCs and VT)
    • Interfascicular Reentrant VT (Belhassen Tachycardia)
    • Idiopathic Polymorphic VT/VF
    • PVC-Induced Cardiomyopathy
    • Pregnancy
    • Older Patients With Comorbidities
    • Medication-Induced Arrhythmias
    • Adult Congenital Heart Disease
    • Subcutaneous Implantable Cardioverter-Defibrillator
    • Wearable Cardioverter-Defibrillator
    • Catheter Ablation
    • Postmortem Evaluation of SCD
    • Terminal Care
    • Shared Decision-Making
  • Tables
    • Table of Definitions of Commonly Used Terms in this Document
    • Important Considerations in the Evaluation of Patients With Known or Suspected VA
    • Pharmacological Characteristics of Available Antiarrhythmic Medications for Treating VA
    • Major Clinical Features Associated With Increased Risk of SCD in Patients With HCM
    • Neuromuscular Disorders Associated With Heart Disease
    • Commonly Used QT-Prolonging Medications
    • Congenital Heart Disease: Risk Factors for VA/SCD
  • Figures
    • SCD Incidence and Total Events
    • SCD and Clinical Subsets
    • Long-QT Syndrome Type 1 (ECG)
    • Long-QT Syndrome Type 2 (ECG)
    • Long-QT Syndrome Type 3 (ECG)
    • Exercise-Induced Polymorphic VT in Catecholaminergic Polymorphic Ventricular Tachycardia (ECG)
    • Brugada Syndrome (ECG)
    • Incremental Cost-Effectiveness of ICD by Years of Life Added (Example)
  • Algorithms
    • Management of Sustained Monomorphic VT
    • Secondary Prevention in Patients With Ischemic Heart Disease
    • Primary Prevention of SCD in Patients With Ischemic Heart Disease
    • Treatment of Recurrent VA in Patients With Ischemic Heart Disease or NICM
    • Secondary and Primary Prevention of SCD in Patients With NICM
    • Prevention of SCD in Patients With HCM
    • Prevention of SCD in Patients With Cardiac Sarcoidosis
    • Prevention of SCD in Patients With Long QT Syndrome
    • Prevention of SCD in Patients With Brugada Syndrome
    • Prevention of SCD in Patients With Long QT Syndrome
    • Prevention of SCD in Patients With Adult Congenital Heart Disease
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The American College of Cardiology (ACC) continues to transform quality cardiovascular care and improve heart health after more than 60 years of existence through its mission, vision and values. The College is proud of its efforts to bring evidence-based clinical care into everyday practice.

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. AHA's Professional Membership is a made up of a robust group of cardiovascular professionals who participate in discovery and dissemination of science.

The Heart Rhythm Society (HRS) is a leading resource on cardiac pacing and electrophysiology. This specialty organization represents medical, allied health, and science professionals from more than 70 countries who specialize in cardiac rhythm disorders.

Description

This pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.

You can also find this product included in these bundles!

Need help?